VERVE-102 - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Persimmon plc targets around 12,500 home completions in 2026 after stronger first-half volumes, even as rising construction, energy and materials costs threaten margins across the United Kingdom housebuilding sector. Representative image.

Persimmon plc raises 2026 home completion target as £50m inflation hit threatens margin recovery

Volodymyr Zelenskyy’s first official visit to Serbia is deepening Kyiv-Belgrade trade and political ties even as Serbia maintains energy links with Russia. Representative image.

Zelenskyy visits Russia-friendly Serbia as Kyiv strikes deepen Moscow’s oil infrastructure crisis

Representative image: An Arko Corp convenience store fuel pump and forecourt in the United States, reflecting the Q2 2026 revenue beat, the 5.7% drop in retail same-store fuel gallons and the ARKO Petroleum Corp agreement to acquire U.S. Petroleum Partners for $205 million.

Arko Corp Q2 revenue tops $2.35bn as APC agrees to $205m USPP acquisition

Lexeo’s second cardiac gene therapy gains FDA support ahead of year-end update

Read More

Pharma Industry News

How VERVE-102 could accelerate the transition from chronic lipid therapy to genomic medicine

Could VERVE-102 shift cholesterol treatment from chronic therapy to one-time gene editing? Explore Eli Lilly and Company’s genomic medicine strategy.

bySoujanya Ravi

May 27, 2026

Read More

General business news

Lilly to expand into cardiovascular gene editing with Verve Therapeutics acquisition

Eli Lilly’s $1.3B acquisition of Verve Therapeutics targets breakthrough one-time gene therapies for high-risk cardiovascular patients. Read more.

byPallavi Madhiraju

June 17, 2025

web analytics